Kenvue Inc. (NYSE:KVUE) Q2 2023 Earnings Conference Call July 20, 2023 7:30 AM ET
Company Participants
Tina Romani - Head, Investor Relations
Thibaut Mongon - Chief Executive Officer
Paul Ruh - Chief Financial Officer
Conference Call Participants
Anna Lizzul - Bank of America
Filippo Falorni - Citi
Andrea Teixeira - JPMorgan
Peter Grom - UBS
Jason English - Goldman Sachs
Steve Powers - Deutsche Bank
Navann Ty - BNP Paribas
Jeremy Fialko - HSBC
Operator
Greetings and welcome to the Kenvue Second Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Tina Romani, Head of Investor Relations for Kenvue. Thank you. Tina, you may begin.
Tina Romani
Good morning, everyone. Joining me on the call today is our Chief Executive Officer, Thibaut Mongon; and our Chief Financial Officer, Paul Ruh.
Please note that today’s call will include forward-looking statements regarding, among other things, our operating and financial performance, market opportunities and our growth. These statements represent our current beliefs or expectations about future events and are subject to various risks, uncertainties and assumptions that could cause our actual results to differ materially. For information regarding these risks and uncertainties, please refer to our earnings materials related to this call posted on our website and our filings with the SEC. During this call, we will also reference certain non-GAAP financial information. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for financial information presented in accordance with GAAP. A reconciliation of these items to the nearest U.S. GAAP measure can be found in this morning’s press release and our presentation available on our IR website.
With that, it’s my pleasure to turn the call over to Thibaut.
Thibaut Mongon
Thank you, Tina. Good morning and thank you for joining our second quarter earnings call and our very first as a public company. Our recent IPO marked an important and exciting milestone in Kenvue’s history. Over the last 135 years, we have established ourselves as the world’s largest pure-play consumer health company. And now as a standalone company, we are looking forward to building on our strong heritage and continuing to deliver on our purpose to realize the extraordinary power of everyday care.
Before we begin, as you may have seen this morning, Johnson & Johnson announced their intended next step in the separation of Kenvue. At this point, we are very limited on what information we can provide other than what has been made public, and as a result, we will not be able to discuss any further details at this time. What I can tell you is that we are ready to take on the next phase in our journey to becoming a fully independent company. For today’s call, I will begin with an overview of our second quarter results, Paul will then take you through a more detailed view of our Q2 financials and 2023 outlook, and then Paul and I will be happy to answer any questions you may have.